Molecule SGLT2 heralds the emergence of cancer

Scientists have identified a symptom of the cancer. Researchers from the U.S., representing the University of California, Los Angeles, found that the high content in the cells of specific molecules of SGLT2 may indicate a precancerous state. This is stated in a press release on MedicalXpress.

Prior to this research had already established that the molecule SGLT2 (sodium-glucose cotransporter 2) may affect the appearance of certain types of cancer, including cancer of the prostate and pancreas. The scientists spoke about the fact that the activation of the molecule SGLT2 is a way to provide cancer glucose.

“Cancer cells need glucose to ensure their survival and growth, while SGLT2 is a protein responsible for glucose transport into cells,” explained the authors.
Thus, the researchers note, increased levels of SGLT2 molecule, is a marker of the growing cancer that seeks provision for its maintenance and progress. In their view, the increased concentration of SGLT2 is an effective benchmark to detect cancer at early stages.

To clarify the role of the ill-fated molecules helped scientists method of positron emission tomography. Specialists have identified the possibility of different glucose transporters in lung cancer cell at different stages of development. As a result, the researchers concluded that the contents in the cells of a large number of SGLT2 molecules “indicates that the newly formed tumors supply themselves with carbohydrates mostly through the sodium-glucose cotransporter”.

Earlier Magicforum wrote that scientists have discovered a new anti-aging body.